Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults

The aging of the world population is expected to be accompanied by increased pneumococcal pneumonia in older adults. To address this, the Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA), a large, randomized, placebo-controlled trial conducted to assess the 13-valent pneumococcal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Isturiz, Raul, Webber, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514202/
https://www.ncbi.nlm.nih.gov/pubmed/26076136
http://dx.doi.org/10.1080/21645515.2015.1043502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514202/
https://www.ncbi.nlm.nih.gov/pubmed/26076136
http://dx.doi.org/10.1080/21645515.2015.1043502

Ejemplares similares